Overview

A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to perform a relative bioavailability study between two formulations of sildenafil citrate.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Citric Acid
Sildenafil Citrate
Sodium Citrate